Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.17) by 29.41 percent. This is a 15.38 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $19.30 million which beat the analyst consensus estimate of $16.96 million by 13.80 percent. This is a 13.52 percent increase over sales of $17.00 million the same period last year.